Insider Stock Trading History of Crane Alan L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Crane Alan L since year 2005. The trader's CIK number is 1294361. At the time of this reporting, Crane Alan L is the Director of T2 Biosystems, Inc. . (stock ticker symbol TTOO). See this page for all insider trading activities at T2 Biosystems, Inc. .

Note that in the past Crane Alan L also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Crane Alan L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-08-12 TTOO T2 Biosystems, Inc. Buy 30,000 11.00 330,000
2014-04-15 CERU Cerulean Pharma Inc. Buy 1,470,582 7.00 10,294,074
2010-04-14 MNTA Momenta Pharmaceuticals Inc Option Ex 35,200 2.95 103,840
2007-01-10 MNTA Momenta Pharmaceuticals Inc Sale 50,000 17.45 872,300
2006-12-18 MNTA Momenta Pharmaceuticals Inc Sale 62,500 16.42 1,026,500
2006-12-08 MNTA Momenta Pharmaceuticals Inc Sale 50,000 17.62 880,850
2006-11-16 MNTA Momenta Pharmaceuticals Inc Sale 62,500 16.37 1,023,250
2006-11-08 MNTA Momenta Pharmaceuticals Inc Sale 50,000 15.19 759,450
2006-10-12 MNTA Momenta Pharmaceuticals Inc Sale 15,300 15.00 229,500
2006-10-13 MNTA Momenta Pharmaceuticals Inc Sale 14,932 15.00 223,980
2006-10-10 MNTA Momenta Pharmaceuticals Inc Sale 9,856 15.00 147,840
2006-10-11 MNTA Momenta Pharmaceuticals Inc Sale 10,200 15.00 153,000
2006-09-11 MNTA Momenta Pharmaceuticals Inc Sale 50,000 15.05 752,500
2006-09-12 MNTA Momenta Pharmaceuticals Inc Sale 38,174 15.00 572,610
2006-09-07 MNTA Momenta Pharmaceuticals Inc Sale 12,402 15.35 190,370
2006-09-05 MNTA Momenta Pharmaceuticals Inc Sale 21,600 15.90 343,375
2006-08-30 MNTA Momenta Pharmaceuticals Inc Sale 50,000 16.41 820,700
2006-08-31 MNTA Momenta Pharmaceuticals Inc Sale 33,000 16.47 543,378
2006-08-08 MNTA Momenta Pharmaceuticals Inc Sale 20,300 15.74 319,420
2006-08-09 MNTA Momenta Pharmaceuticals Inc Sale 29,700 15.21 451,618

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Crane Alan L (Director of T2 Biosystems, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.